Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Plasma fasting glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
Plasma 2-hr post-prandial glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
Urine glucose chemical titer measurement |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
blodglucosetolerance |
Component |
False |
Glucose |
Inferred relationship |
Some |
|
blodsukkertolerance |
Component |
False |
Glucose |
Inferred relationship |
Some |
|
Fluid sample glucose measurement (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
Lunch time blood sugar measurement (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
Supper time blood sugar measurement (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
Bedtime blood sugar measurement (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
BM stix glucose measurement |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
60 minute blood glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
120 minute blood glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
90 minute blood glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
150 minute blood glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
30 minute plasma glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
60 minute plasma glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
120 minute plasma glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
150 minute plasma glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
30 minute serum glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
60 minute serum glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
120 minute serum glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
30 minute blood glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
90 minute plasma glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
90 minute serum glucose measurement |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
150 minute serum glucose measurement |
Component |
True |
Glucose |
Inferred relationship |
Some |
1 |
Glucose tolerance test NOS |
Component |
False |
Glucose |
Inferred relationship |
Some |
|
Glucose [endocrine] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
glucose 5 % blæreskyllevæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
Glucose-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
1 |
Glucose powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
1 |
glucose 10 % infusionsvæske, opløsning, flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
glucose 15 % infusionsvæske, opløsning i flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
glucose 20 % infusionsvæske, opløsning i flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
glucose 40 % infusionsvæske, opløsning i flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
glucose 50 % infusionsvæske, opløsning i flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
glucose 5 % infusionsvæske, opløsning i flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
glucose 50 % injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
glucose 70 % infusionsvæske, opløsning i pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
Faecal clinitest |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
Urine clinitest (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
Product containing glucose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
1 |
kombinationspræparat med natriumlactat i halv styrke/glucose 5 %, infusionsvæske, opløsning i pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
Ringer-laktat, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
kombinationspræparat med natriumlactat i halv styrke, infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
kaliumchlorid 10 mmol/glucose 5 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
kaliumchlorid 13,5 mmol/glucose 5 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
kaliumchlorid 20 mmol/glucose 5 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
kaliumchlorid 20 mmol/glucose 5 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
kaliumchlorid 27 mmol/glucose 5 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
kaliumchlorid 40 mmol/glucose 5 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
Product containing alpha-glucosidase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
bupivacain 0,5 % + glucose injektionsvæske, opløsning, ampul a 4 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
bupivacain + glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
2 |
kombinationspræparat med natriumlactat infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
kombinationspræparat med natriumlactat infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
glucose 10 % infusionsvæske, opløsning i polyætylenflaske a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
glucose 10 % infusionsvæske, opløsning i polyætylenflaske a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
glucose 20 % infusionsvæske opløsning polyætylenflaske a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
glucose 20 % opløsning infusionsvæske i ampul a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
glucose 50 % opløsning, infusionsvæske, i ampul a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
glucose 50 % infusionsvæske, opløsning i hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
glucose 50 % infusionsvæske, opløsning i pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
glucose 50 % infusionsvæske, opløsning, pose a 3 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
glucose 50 % infusionsvæske, opløsning i polyætylenflaske a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
glucose 5 % infusionsvæske, opløsning i pose a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
glucose 5 % infusionsvæske, opløsning i pose a 150 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
glucose 5 % infusionsvæske, opløsning i pose a 250 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
glucose 5 % infusionsvæske, opløsning i pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
Fecal glucose level (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
Dialysis fluid glucose measurement (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
Blood glucose series (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
Ascitic fluid glucose measurement (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Some |
2 |
bupivacainhydrochlorid 7,5 mg/glucose 82,5 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
lidocainhydrochlorid + glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,1 %/glucose 5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,2 %/glucose 5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,4 %/glucose 5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,6 % + glucose 5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,2 % + glucose 5 %, Polyfusor-flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
lidocainhydrochlorid 0,4 % + glucose 5 % i Polyfusor-flaske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
lidocainhydrochlorid 5 %/glucose 7,5 % injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
Product containing caffeine and glucose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
2 |
Product containing glucose and molasses (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
2 |
milrinon + glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
natriumchlorid 0,9 %/glucose 5 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
alkohol + dekstsrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
natriumchlorid 0,9 %/glucose 5 % infusionsvæske, opløsning, polyætylenflaske a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
Glucose 400 mg/g oral gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
glucose 5 g/100 ml (5 %) injektionsvæske, opløsning, hætteglas a 25 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
Ringers opløsning med lactat + 5 % glucose + 0,15 % kaliumhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
kaliumchlorid 40 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
cefoxitin + glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
kaliumchlorid 27 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
Dextrose + potassium chloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
Product containing glucose and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Some |
2 |
glucose 5 g/100 ml (5 %) injektionsvæske, opløsning, hætteglas a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
morphinsulfat + glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
natriumchlorid 0,18 %/glucose 5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
glucose 30 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
dekstrose 5 g/100 ml (5 %) iinjektionsvæske, opløsning, sprøjte a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|
natriumchlorid 0,18 %/glucose 4 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Some |
|